237 related articles for article (PubMed ID: 34069335)
21. Single-cell analyses of metastatic bone marrow in human neuroblastoma reveals microenvironmental remodeling and metastatic signature.
Mei S; Alchahin AM; Embaie BT; Gavriliuc IM; Verhoeven BM; Zhao T; Li X; Jeffries NE; Pepich A; Sarkar H; Olsen TK; Wickström M; Stenman J; Reina-Bedoya O; Kharchenko PV; Saylor PJ; Johnsen JI; Sykes DB; Kogner P; Baryawno N
JCI Insight; 2024 Feb; 9(6):. PubMed ID: 38358826
[TBL] [Abstract][Full Text] [Related]
22. Clinical implications of minimal disease in the bone marrow and peripheral blood in neuroblastoma.
Shono K; Tajiri T; Fujii Y; Suita S
J Pediatr Surg; 2000 Oct; 35(10):1415-20. PubMed ID: 11051140
[TBL] [Abstract][Full Text] [Related]
23. CD4
Morandi F; Pozzi S; Barco S; Cangemi G; Amoroso L; Carlini B; Pistoia V; Corrias MV
Oncoimmunology; 2016; 5(12):e1249553. PubMed ID: 28123887
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic utility of PHOX2B in primary and treated neuroblastoma and in neuroblastoma metastatic to the bone marrow.
Hata JL; Correa H; Krishnan C; Esbenshade AJ; Black JO; Chung DH; Mobley BC
Arch Pathol Lab Med; 2015 Apr; 139(4):543-6. PubMed ID: 25822764
[TBL] [Abstract][Full Text] [Related]
25. ppGalNAc-T13: a new molecular marker of bone marrow involvement in neuroblastoma.
Berois N; Blanc E; Ripoche H; Mergui X; Trajtenberg F; Cantais S; Barrois M; Dessen P; Kågedal B; Bénard J; Osinaga E; Raguénez G
Clin Chem; 2006 Sep; 52(9):1701-12. PubMed ID: 16873292
[TBL] [Abstract][Full Text] [Related]
26. Effects of stem cell factor and other bone marrow-derived growth factors on the expression of adhesion molecules and proliferation of human neuroblastoma cells.
Beck D; Gross N; Beretta Brognara C
Eur J Cancer; 1995; 31A(4):467-70. PubMed ID: 7576947
[TBL] [Abstract][Full Text] [Related]
27. Immune profiling of the bone marrow microenvironment in patients with high-risk localized prostate cancer.
Heninger E; Sethakorn N; Kosoff D; Hematti P; Kuczler MD; Pienta KJ; Lang JM
Oncotarget; 2020 Nov; 11(46):4253-4265. PubMed ID: 33245727
[TBL] [Abstract][Full Text] [Related]
28. [Clinical characteristics and prognosis of high-risk neuroblastoma with bone marrow metastasis in children].
Fan HJ; Huang C; Su Y; Wang XD; Zhou YC; Duan C; Zhao W; Zhao Q; Jin M; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Nov; 57(11):863-869. PubMed ID: 31665841
[No Abstract] [Full Text] [Related]
29. Measuring circulating neuroblastoma cells by quantitative reverse transcriptase-polymerase chain reaction analysis.
Cheung IY; Sahota A; Cheung NK
Cancer; 2004 Nov; 101(10):2303-8. PubMed ID: 15484213
[TBL] [Abstract][Full Text] [Related]
30.
Yue ZX; Huang C; Gao C; Xing TY; Liu SG; Li XJ; Zhao Q; Wang XS; Zhao W; Jin M; Ma XL
Cancer Cell Int; 2017; 17():43. PubMed ID: 28367105
[No Abstract] [Full Text] [Related]
31. Control of neuroblastoma cell proliferation and differentiation by human bone marrow.
Hahn T; Or R; Bruchelt G; Malach L; Karov Y; Lefshitz-Mercer B; Evron R; Barak Y
Cancer; 1996 Jun; 77(12):2614-21. PubMed ID: 8640713
[TBL] [Abstract][Full Text] [Related]
32. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
33. Expression of stem cell factor and its receptor by human neuroblastoma cells and tumors.
Beck D; Gross N; Brognara CB; Perruisseau G
Blood; 1995 Oct; 86(8):3132-8. PubMed ID: 7579408
[TBL] [Abstract][Full Text] [Related]
34. Deregulation of focal adhesion pathway mediated by miR-659-3p is implicated in bone marrow infiltration of stage M neuroblastoma patients.
Stigliani S; Scaruffi P; Lagazio C; Persico L; Carlini B; Varesio L; Morandi F; Morini M; Gigliotti AR; Esposito MR; Viscardi E; Cecinati V; Conte M; Corrias MV
Oncotarget; 2015 May; 6(15):13295-308. PubMed ID: 25980492
[TBL] [Abstract][Full Text] [Related]
35. IL-10 and ARG-1 concentrations in bone marrow and peripheral blood of metastatic neuroblastoma patients do not associate with clinical outcome.
Morandi F; Croce M; Cangemi G; Barco S; Rigo V; Carlini B; Amoroso L; Pistoia V; Ferrini S; Corrias MV
J Immunol Res; 2015; 2015():718975. PubMed ID: 25961062
[TBL] [Abstract][Full Text] [Related]
36. [The TH, ELAVL4 and GD2 gene expression as diagnostic markers of bone marrow lesions in patients with neuroblastoma].
Druĭ AE; Tsaur GA; Popov AM; Tuponogov SN; Shorikov EV; Tsvirenko SV; Savel'ev LI; Fechina LG
Vopr Onkol; 2012; 58(4):514-20. PubMed ID: 23607207
[TBL] [Abstract][Full Text] [Related]
37. The Application of and Factors Influencing, the NB5 Assay in Neuroblastomas.
Wang Z; Wang C; Xu Y; Le J; Jiang Y; Yao W; Wang H; Li K
Front Oncol; 2021; 11():633106. PubMed ID: 34055604
[TBL] [Abstract][Full Text] [Related]
38. Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.
Kushner BH; Yeung HW; Larson SM; Kramer K; Cheung NK
J Clin Oncol; 2001 Jul; 19(14):3397-405. PubMed ID: 11454888
[TBL] [Abstract][Full Text] [Related]
39. Neuroblastoma metastatic to the central nervous system. The Memorial Sloan-kettering Cancer Center Experience and A Literature Review.
Kramer K; Kushner B; Heller G; Cheung NK
Cancer; 2001 Apr; 91(8):1510-9. PubMed ID: 11301399
[TBL] [Abstract][Full Text] [Related]
40. Autocrine proliferation of neuroblastoma cells is partly mediated through neurokinin receptors: relevance to bone marrow metastasis.
Mukerji I; Ramkissoon SH; Reddy KK; Rameshwar P
J Neurooncol; 2005 Jan; 71(2):91-8. PubMed ID: 15690122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
